The retail pharmacy industry is at a crossroads. The traditional economic model, once robust and reliable, continues to show signs of significant strain and may even be inching close to its breaking point.
America’s large chain drug stores have been in a tough spot. Walgreens’ fourth quarter report shed light on a whopping $3.1 billion in net losses for the calendar year.
Estimates project that prescription drug middlemen – pharmacy benefit managers (PBMs) – more than doubled their revenue over the course of the last decade and will do so again in the current decade.
At the beginning of the month, retail pharmacy advocates were engaged in a full-court press to convince members of Congress, who were locked in a protracted battle over federal spending and a possible government shutdown, to include meaningful PBM reform in a final budget deal.
Stew Turley passed away last month, a victim of deteriorating health and advancing age.
which included David Best, president and chief operating officer of Coborn’s Inc.; Sandy Douglas, chief executive officer of
On the eve of the annual NACDS regional chain conference, about to convene in South Florida as this piece is written, now is perhaps the perfect time to reflect on the stunning success regional drug chains are experiencing in the U.S. chain drug community.
The last year has been remarkable for medical advancement, and with thousands of therapies in the development pipeline, 2024 promises to be just as exciting.
CVS, Rite Aid and Walgreens — succeeded as much for the zeal, creativity and accomplishments of their chief merchants as for the directions provided by their senior management. Indeed, it was a time when people like Vern Brunner, Chris Bodine and
Like most major retailers, CVS Pharmacy has entered the media business with the intent of broadening and deepening consumer engagement, working with CPG companies to better serve shoppers and grow categories, and establishing a new revenue stream.
When the history of Doug McMillon’s tenure as chief executive officer of Walmart is written, the central theme is sure to be the transformation of the company from one entrenched in brick-and-mortar retailing into a multidimensional enterprise.
as we obviously have — then it’s equally true that this is a new era for the regional chain executive. Explore the National Association of Chain Drug Stores board of directors and you’ll find that it’s well represented,
a great friend of NACDS — stand the
Viewed from almost any perspective, December 13, 2023, was a significant day in the history of mass retailing in America.
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. 2023 was a pivotal year for health policy, to say the least.
